Cancer Center Physician Receives $150,000 New Investigator Research Grant to Study Treatment-Resistant Leukemia

[University of Cincinnati] The University of Cincinnati Cancer Center’s Dr. Sarah Skuli, has received a two-year, $150,000 New Investigator Research Grant from the Leukemia Research Foundation. The funds will go toward a project that focuses on leukemia carrying mutations in the TP53 gene, which leads to very poor outcomes for patients.